DK0657164T3 - Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid - Google Patents

Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid

Info

Publication number
DK0657164T3
DK0657164T3 DK94308954T DK94308954T DK0657164T3 DK 0657164 T3 DK0657164 T3 DK 0657164T3 DK 94308954 T DK94308954 T DK 94308954T DK 94308954 T DK94308954 T DK 94308954T DK 0657164 T3 DK0657164 T3 DK 0657164T3
Authority
DK
Denmark
Prior art keywords
polyalkylene glycol
pharmaceutical compositions
compositions containing
glycol glyceride
staurosporine derivatives
Prior art date
Application number
DK94308954T
Other languages
Danish (da)
English (en)
Inventor
Roy Lindsay Allen Henry
Graham Paul Matthews
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0657164T3 publication Critical patent/DK0657164T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94308954T 1993-12-11 1994-12-02 Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid DK0657164T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325395A GB9325395D0 (en) 1993-12-11 1993-12-11 Compositions

Publications (1)

Publication Number Publication Date
DK0657164T3 true DK0657164T3 (da) 2000-04-17

Family

ID=10746475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94308954T DK0657164T3 (da) 1993-12-11 1994-12-02 Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid

Country Status (17)

Country Link
US (1) US5736542A (fr)
EP (1) EP0657164B1 (fr)
JP (1) JPH07196512A (fr)
KR (1) KR100366176B1 (fr)
AT (1) ATE185970T1 (fr)
AU (1) AU692801B2 (fr)
CA (1) CA2137764C (fr)
DE (1) DE69421366T2 (fr)
DK (1) DK0657164T3 (fr)
ES (1) ES2140512T3 (fr)
GB (1) GB9325395D0 (fr)
GR (1) GR3032368T3 (fr)
IL (1) IL111872A (fr)
NZ (1) NZ270109A (fr)
PH (1) PH31454A (fr)
PT (1) PT657164E (fr)
ZA (1) ZA949824B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
GB9903547D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
DE19917990A1 (de) * 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
WO2001004125A1 (fr) 1999-07-13 2001-01-18 Kyowa Hakko Kogyo Co., Ltd. Derives de staurosporine
DE10042137A1 (de) * 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
PT1372611E (pt) * 2001-03-26 2006-08-31 Novartis Ag Composicao farmaceutica compreendendo uma estaurosporina francamente soluvel em agua, um tensioactivo et um polimero soluvel em agua
KR101032281B1 (ko) * 2003-03-03 2011-05-06 플로리안 랑 진단 및 치료 표적으로서의 ｓｇｋ１
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
EP1653973A1 (fr) 2003-08-08 2006-05-10 Novartis AG Combinaisons contenant des staurosporines
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
AU2006210994A1 (en) * 2005-02-07 2006-08-10 Topotarget Uk Limited Assays for agents with selective cytotoxicty to HDAC resistant cell lines
US9994585B2 (en) 2007-12-31 2018-06-12 Aphios Corporation Transplantation therapies
US20100168219A1 (en) * 2008-12-31 2010-07-01 Jonathan Steven Alexander Chronic inflammation and transplantation
US9034347B2 (en) 2011-12-19 2015-05-19 Arphios Corporation Drug delivery system and method for the treatment of neuro-degenerative disease
CN105228614A (zh) 2012-11-28 2016-01-06 阿菲欧斯公司 用于治疗神经退化疾病和其它疾病的组合治疗剂和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185719A (ja) * 1984-03-06 1985-09-21 Ajinomoto Co Inc 抗腫瘍剤
JPH0699311B2 (ja) * 1986-11-06 1994-12-07 旭化成工業株式会社 抗血管レン縮剤および血管弛緩剤
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
JPH01143877A (ja) * 1987-11-30 1989-06-06 Asahi Chem Ind Co Ltd スタウロスポリン誘導体
EP0383919A4 (en) * 1988-02-04 1992-08-05 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
JPH0725786A (ja) * 1990-05-16 1995-01-27 Univ Rockefeller アルツハイマー病を伴うアミロイドーシスの治療
WO1992017181A1 (fr) * 1991-03-29 1992-10-15 The United States Of America, Represented By The Secretary, United States Department Of Commerce Procedes et compositions pharmaceutiques servant a prevenir la formation de tumeurs de la peau et provoquant la regression de tumeurs existantes
JPH0597708A (ja) * 1991-10-02 1993-04-20 Lion Corp 歯周病治療剤
WO1993007153A1 (fr) * 1991-10-10 1993-04-15 Schering Corporation Derives de staurosporine 4'-(n-substituee-n-oxydee)
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤

Also Published As

Publication number Publication date
GB9325395D0 (en) 1994-02-16
EP0657164A1 (fr) 1995-06-14
PT657164E (pt) 2000-04-28
ATE185970T1 (de) 1999-11-15
ZA949824B (en) 1995-07-13
PH31454A (en) 1998-11-03
KR960021018A (ko) 1996-07-18
AU692801B2 (en) 1998-06-18
CA2137764A1 (fr) 1995-06-12
CA2137764C (fr) 2006-02-07
US5736542A (en) 1998-04-07
AU8030894A (en) 1995-06-22
IL111872A (en) 1998-02-08
NZ270109A (en) 1996-11-26
EP0657164B1 (fr) 1999-10-27
JPH07196512A (ja) 1995-08-01
GR3032368T3 (en) 2000-04-27
IL111872A0 (en) 1995-06-29
DE69421366D1 (de) 1999-12-02
KR100366176B1 (ko) 2003-03-03
DE69421366T2 (de) 2000-03-23
ES2140512T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
DK0657164T3 (da) Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid
ATE153854T1 (de) Stabile pharmazeutische zubereitung mit fumagillolderivaten
DE69232818D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
LV11884A (lv) Ciklosporina oralas arstnieciskas formas ar augstu biopieejamibu
JPS5777626A (en) Palatable composition containing oil or oily substance
SE8009103L (sv) Farmaceutiska kompositioner innehallande en kortikosteroidsubstans
DE60205633D1 (de) Orale pharmazeutische zusammensetzung mit einem wirkstoff, der bei seiner ersten darmpassage starken wirkungen ausgesetzt werden kann
KR950010875A (ko) 피부외용제
JPS5793911A (en) Drug composition
HU896123D0 (en) Pharmaceutical compositions
IL86395A (en) Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
EA200200415A1 (ru) Композиция фармацевтического носителя
GB2021409A (en) Pharmaceutical composition
JPS5772908A (en) Removing agent for make-up cosmetic
ES2141049B1 (es) Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
JPS5640607A (en) Drug composition
GR900100076A (en) Preparation method of novel pharmaceutical forms of cyclosporine
IT1226144B (it) Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi.